| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 533,989 | 565,629 | 601,986 | 630,424 | | Cost of Revenue | (184,651) | 88,499 | 96,152 | 100,566 | | | Gross Profit | 718,640 | 477,130 | 505,834 | 529,858 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 459,555 | 190,950 | 199,345 | 192,113 | | Non Recurring |
-
|
-
|
-
| 746,555 | | Others | 142,579 | 142,322 | 142,845 | 120,016 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 116,506 | 143,858 | 163,644 | (528,826) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,106) | (70,781) |
-
| 33,627 | | Earnings Before Interest And Taxes | (314,449) | 73,077 | 163,644 | (495,199) | | Interest Expense | (360,305) | 161,470 | 198,835 | 205,120 | | Income Before Tax | 45,856 | (88,393) | (35,191) | (700,319) | | Income Tax Expense | 21,925 | (12,911) | 366,019 | (337,924) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (53,956) | (75,482) | (401,210) | (362,395) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,931 | (75,482) | (401,210) | (362,395) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,931 | ($75,482) | ($401,210) | ($362,395) |
|
1.75% Nasdaq 
0.002 (18.18%) 
Income Statement
